Skip to Content

Vorasidenib (Voranigo®)

Download PQI pdf 0.27MB

By: Andrea Gómez, PharmD, BCACP

About this PQI

The purpose of this PQI is to provide information on the use of vorasidenib (Voranigo®) in the treatment of isocitrate dehydrogenase mutant, low-grade glioma, as well as discuss clinical pearls to enhance appropriate patient selection, monitoring, and follow-up.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI